Literature DB >> 8678057

Childhood steroid-sensitive nephrotic syndrome: does the histology matter?

N J Webb1, M A Lewis, J Iqbal, P J Smart, M Lendon, R J Postlethwaite.   

Abstract

Renal biopsy specimens from 51 children with steroid-sensitive nephrotic syndrome who were following a frequently relapsing or steroid-dependent course were reviewed by two histopathologists. In all cases the biopsy was performed prior to the commencement of an 8-week course of cyclophosphamide. The clinical courses of these patients both prebiopsy and for a minimum of 2 years after completion of cyclophosphamide therapy were analyzed using retrospective case note analyses. The distribution of histologic diagnoses differed significantly from that reported by the International Study of Kidney Disease in Children in their study of children who underwent biopsy at the time of presentation, there being an excess of focal segmental glomerulosclerosis and mild mesangial hypercellularity in this series. The prebiopsy clinical course did not predict for histologic diagnosis, and there was no correlation between prebiopsy course or histology and postcyclophosphamide course. The findings of this study support the clinical impression that steroid sensitivity rather than histology is the major determinant of prognosis in childhood nephrotic syndrome and that frequency of relapse alone is not an indication for biopsy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8678057     DOI: 10.1016/s0272-6386(96)90157-2

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome.

Authors:  Mohan Shenoy; Nicholas D Plant; Malcolm A Lewis; Mark G Bradbury; Rachel Lennon; Nicholas J A Webb
Journal:  Pediatr Nephrol       Date:  2010-01-27       Impact factor: 3.714

2.  Association of low birth weight and prematurity with clinical outcomes of childhood nephrotic syndrome: a prospective cohort study.

Authors:  Natalia Konstantelos; Tonny Banh; Viral Patel; Jovanka Vasilevska-Ristovska; Karlota Borges; Neesha Hussain-Shamsy; Damien Noone; Diane Hebert; Seetha Radhakrishnan; Christoph P B Licht; Valerie Langlois; Rachel J Pearl; Rulan S Parekh
Journal:  Pediatr Nephrol       Date:  2019-04-11       Impact factor: 3.714

3.  Steroid Sensitive Nephrotic Syndrome: Revised Guidelines.

Authors:  Aditi Sinha; Arvind Bagga; Sushmita Banerjee; Kirtisudha Mishra; Amarjeet Mehta; Indira Agarwal; Susan Uthup; Abhijeet Saha; Om Prakash Mishra
Journal:  Indian Pediatr       Date:  2021-03-20       Impact factor: 1.411

4.  Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis.

Authors:  Ibrahim F Shatat; Morris Schoeneman; Joseph T Flynn; Robert P Woroniecki
Journal:  Pediatr Nephrol       Date:  2007-02-10       Impact factor: 3.714

5.  Long-term effects of levamisole treatment in childhood nephrotic syndrome.

Authors:  Viktória Sümegi; Ibolya Haszon; Béla Iványi; Csaba Bereczki; Ferenc Papp; Sándor Túri
Journal:  Pediatr Nephrol       Date:  2004-12       Impact factor: 3.714

Review 6.  Is focal segmental glomerulosclerosis increasing in patients with nephrotic syndrome?

Authors:  Fábio Fernandes Borges; Luciana Shiraichi; Marcos Paulo Hippólito da Silva; Eduardo Isaac Nishimoto; Paulo Cesar Koch Nogueira
Journal:  Pediatr Nephrol       Date:  2007-06-06       Impact factor: 3.714

7.  Morphological Features of Minimal Change Disease and Focal Segmental Glomerulosclerosis Using Repeat Biopsy and Parietal Epithelial Cell Marker.

Authors:  Tomo Suzuki; Kaori Kohatsu; Wei Han; Shiika Watanabe; Koichi Yahagi; Mayumi Nakata; Toshiharu Ueno; Daisuke Ichikawa; Naohiko Imai; Sayuri Shirai; Junki Koike; Yugo Shibagaki
Journal:  Kidney Dis (Basel)       Date:  2020-01-31

8.  Ten year experience of pediatric kidney biopsies from a single center in Pakistan.

Authors:  A Absar; M Diamond; Y Sonia; R Arshalooz; A Safia; K Waqar; P Shahid
Journal:  Indian J Nephrol       Date:  2010-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.